Michael E. Meyers, Director at MEMORY PHARMACEUTICALS CORP (MEMY), bought 17,525 shares at $1.11 ($19K) on 2006-10-16, disclosed to the SEC on 2006-10-18.
Open-market purchase of $19k MEMY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.